Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH; Alzheimer's Association; Society of Nuclear Medicine and Molecular Imaging; Amyloid Imaging Taskforce.

Alzheimers Dement. 2013 Jan;9(1):e-1-16.

2.

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH.

J Nucl Med. 2013 Mar;54(3):476-90. doi: 10.2967/jnumed.113.120618. Epub 2013 Jan 28. Review.

3.

Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.

Laforce R, Rosa-Neto P, Soucy JP, Rabinovici GD, Dubois B, Gauthier S.

Can J Neurol Sci. 2016 Jul;43(4):503-12. doi: 10.1017/cjn.2015.401. Epub 2016 Feb 26.

PMID:
26916179
4.

Recommendations from the Italian Interdisciplinary Working Group (AIMN, AIP, SINDEM) for the utilization of amyloid imaging in clinical practice.

Guerra UP, Nobili FM, Padovani A, Perani D, Pupi A, Sorbi S, Trabucchi M.

Neurol Sci. 2015 Jun;36(6):1075-81. doi: 10.1007/s10072-015-2079-3.

PMID:
25616445
5.

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM; Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.

Alzheimers Dement. 2013 Jul;9(4):e106-9. doi: 10.1016/j.jalz.2013.06.001.

PMID:
23809369
6.

Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.

Rabinovici GD, Karlawish J, Knopman D, Snyder HM, Sperling R, Carrillo MC.

Alzheimers Dement. 2016 Apr;12(4):510-5. doi: 10.1016/j.jalz.2016.03.002.

PMID:
27103054
7.

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S.

Amyloid. 2014 Sep;21(3):143-8. doi: 10.3109/13506129.2014.926267. Epub 2014 Jun 11. Review.

PMID:
24919109
8.

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM.

J Nucl Med. 2013 Jul;54(7):1011-3. doi: 10.2967/jnumed.113.127068. Epub 2013 Jun 10.

9.

Will PET amyloid imaging lead to overdiagnosis of Alzheimer dementia?

Dubroff JG, Nasrallah IM.

Acad Radiol. 2015 Aug;22(8):988-94. doi: 10.1016/j.acra.2015.02.005. Epub 2015 Jun 19. Review.

PMID:
26100192
10.

Molecular imaging of dementia.

Mori T, Maeda J, Shimada H, Higuchi M, Shinotoh H, Ueno S, Suhara T.

Psychogeriatrics. 2012 Jun;12(2):106-14. doi: 10.1111/j.1479-8301.2012.00409.x. Review.

11.

[German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].

Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, Coenen HH, la Fougère C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Schreckenberger M, Tatsch K, Langen KJ, Sabri O.

Nuklearmedizin. 2016 Aug 5;55(4):129-37. doi: 10.3413/Nukmed-0816-16-04. Epub 2016 Apr 15. German.

PMID:
27080914
12.

Use of florbetapir-PET for imaging beta-amyloid pathology.

Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, Sabbagh MN, Sadowsky CH, Reiman EP, Zehntner SP, Skovronsky DM; AV45-A07 Study Group.

JAMA. 2011 Jan 19;305(3):275-83. doi: 10.1001/jama.2010.2008. Erratum in: JAMA. 2011 Mar 16;305(11):1096. Reiman, P Eric M [corrected to Reiman, Eric M].

PMID:
21245183
13.
14.

Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET.

Altomare D, Ferrari C, Festari C, Guerra UP, Muscio C, Padovani A, Frisoni GB, Boccardi M; Incremental Diagnostic Value of Amyloid PET With [(18)F]-Florbetapir (INDIA-FBP) Working Group.

Alzheimers Dement. 2018 Apr 18. pii: S1552-5260(18)30104-3. doi: 10.1016/j.jalz.2018.02.022. [Epub ahead of print]

PMID:
29679576
15.

FDG-PET and amyloid-PET imaging: the diverging paths.

Perani D.

Curr Opin Neurol. 2014 Aug;27(4):405-13. doi: 10.1097/WCO.0000000000000109. Review.

PMID:
24927239
16.

[The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques].

Tsolaki M, Trontzos C, Kazis A.

Hell J Nucl Med. 2005 Sep-Dec;8(3):187-90. Review. Greek, Modern.

PMID:
16390030
17.

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.

Laforce R Jr, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014.

18.

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.

Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A.

Brain. 2011 Jan;134(Pt 1):301-17. doi: 10.1093/brain/awq349. Epub 2010 Dec 13.

19.

Brain amyloid imaging.

Rowe CC, Villemagne VL.

J Nucl Med. 2011 Nov;52(11):1733-40. doi: 10.2967/jnumed.110.076315. Epub 2011 Sep 14.

Supplemental Content

Support Center